+8.78%
Today
Loading 1D prices…
Company profile
BioNexus Gene Lab Corp., together with its subsidiaries, focuses on the sale of chemical raw materials for the manufacture of industrial, medical, appliance, aero, automotive, mechanical, and electronic products in Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. The company operates through three segments: Trading of Industrial Chemicals; Provision for Genomic Screening Services; and Investment Holding. It offers various chemical raw material products, including polyester resin SHCP 268, a thixotropic, quick-curing unsaturated polyester resin suitable as a general-purpose resin; polyester resin 9509, a general-purpose material used in the production of marine boats and water slides; and polyester resin 2802, which is used as a component in the pultrusion process. The company's products are used in producing various finished goods, such as handrails, bench tops, and automotive and aero parts; paneling for hospital, laboratory, and industrial clean rooms; and covers for various instruments used in manufacturing. It develops and provides non-invasive liquid biopsy tests for the early detection of biomarkers. BioNexus Gene Lab Corp. was incorporated in 2017 and is based in Kuala Lumpur, Malaysia.
Sector
Health Care
Industry
Services-Medical Laboratories
Exchange
Nasdaq
Display currency
USD
Location
Kuala Lumpur, United States
Employees
19
Fiscal year end
1231
CIK
1737523
Session & valuation
Latest annual period
Deterministic peer set
Exact regulatory industry matches, ranked by nearest market capitalization.
| Company | Market cap | Revenue | Net margin | Diluted EPS | Today | Consensus |
|---|---|---|---|---|---|---|
| ACONAclarion Inc. Common Stock | $7.5M | $75.7K | -9551.87% | -$13.61 | +2.36% | Hold |
| AMSAmerican Shared Hospital Services Common Stock | $9.8M | $28.1M | -5.53% | -$0.23 | 0.00% | Unrated |
| ADVBAdvanced Biomed Inc. Common Stock | $13.5M | $0.00 | — | $5.21 | -7.46% | Unrated |
| MDXHMDxHealth SA Ordinary Shares | $67.2M | $107.9M | -31.07% | -$0.67 | +4.29% | Buy |
| SERASera Prognostics Inc. Class A Common Stock | $80.1M | $81K | -39417.28% | -$0.67 | -0.98% | Buy |